RHÖN-KLINIKUM AG / Issue of Debt04.03.2010 18:28Dissemination of a Corporate News, transmitted byDGAP - a company of EquityStory AG.The issuer / publisher is solely responsible for the content of this announcement.
Not for publication or distribution to US persons or in the USA or anyother jurisdiction in which offers or sales of securities of RHÖN-KLINIKUMAG are prohibited by law.RHÖN-KLINIKUM AG today successfully issued a bond (ISIN XS0491047154) witha volume ofEUR 400,000,000 and a maturity of six years. The coupon of the bond is3.875%, and the issue price was fixed at 99.575%. The bond is being offeredwith a denomination of EUR 1,000. The issue proceeds will be used torefinance existing financial liabilities as well as for general corporatepurposes.For the execution of the transaction, Credit Suisse Securities (Europe)Limited, UniCredit Bank AG and WestLB AG were appointed as jointbookrunners. Prior to the transaction, RHÖN-KLINIKUM AG conducted aroadshow where it met approx. 100 investors in Germany, Austria,Switzerland and the UK.The bond was more than 12 times oversubscribed. As a result of thissignificant oversubscription, the spread was fixed at 125 bps which wasslightly below the initial spread guidance of 130 to 135 bps. In total,some 350 investors from more than 25 countries subscribed. By region,demand was focused on Germany (39%), UK/Ireland (23%) andAustria/Switzerland (14%). More than 50% was placed with fund managers,approx. 35% with banks, savings banks and Volksbanken as well as 6% withinsurers.'With this bond transaction in the international capital market, we havenoticeably broadened our financing and investor base. The high demand forour bond underscores RHÖN-KLINIKUM AG's special standing and leading rolein the capital market', explained Wolfgang Pföhler, chairman of the Boardof Management of RHÖN-KLINIKUM AG.RHÖN-KLINIKUM AG is rated Baa2 by Moody's with a stable outlook. These materials are not for distribution, directly or indirectly, in orinto the United States of America (including its territories anddependencies, any State of the United States of America and the District ofColumbia).These materials do not constitute or form part of any offer or solicitationto purchase or subscribe for securities.The bonds of RHÖN-KLINIKUM AG mentioned herein may not be offered or soldwithin the United States of America or to US persons unless they areregistered or exempted from the registration obligation in accordance withthe U.S. Securities Act of 1933 in its version as amended (the 'SecuritiesAct'). The bonds have not been, and will not be, registered under theSecurities Act and will not be offered, sold or delivered in the UnitedStates of America. The bonds are subject, inter alia, to US tax law.Boris TrammHead of Investor Relations Tel.: (09771) 65-1318 Fax: (09771) 65-1736 E-mail: boris.tramm@rhoen-klinikum-ag.comEsther WalterHead of Group Press and Public RelationsTel.: (09771) 65 - 1322 Fax: (09771) 65 - 1820E-mail: esther.walter@rhoen-klinikum-ag.com04.03.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.Media archive at www.dgap-medientreff.de and www.dgap.de
 Language: EnglishCompany: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale DeutschlandPhone: +49 (0)9771 - 65-0Fax: +49 (0)9771 - 97 467E-mail: rka@rhoen-klinikum-ag.comInternet: www.rhoen-klinikum-ag.comISIN: DE0007042301WKN: 704230Indices: MDAXListed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service